Jared Whitlock

Reporter

Email: jwhitlock@sdbj.com
Phone: 858-634-4636 Extension: 3130

Recent Stories

Toft Group Hires COO

Ronald Giannotti has been appointed as COO of Toft Group Executive Search, a San Diego-based firm centered on executive searches in life sciences and health care.

Tease photo

Center for Medical Device Manufacturing Opens in Carlsbad

A biomedical incubator has opened facilities for additive manufacturing and R&D in Carlsbad to aid medical device product development.

Deal Gives Vividion Small Molecule War Chest

BIOTECH: Co. to Take on Previously ‘Undruggable’ Proteins

Even by startup standards, Vividion Therapeutics CEO Diego Miralles makes bold claims. He said the venture marks a “once-in-a-generation opportunity” to build a transformative company in San Diego.

Tease photo

Human Longevity Taps Scott Sorensen as CTO

San Diego’s Human Longevity, Inc. has named Scott Sorensen chief technology officer as the company brings its genomics and health program to more locations globally.

Heron Therapeutics’ Stock Rises on Data for Opioid Alternative Anesthetic

A Heron Therapeutics postoperative pain anesthetic billed as an alternative to opioids achieved positive late-stage trial results, boosting the San Diego company’s stock.

Twist Bioscience Opens Carlsbad Office

San Francisco-based Twist Bioscience Corporation has opened a 2,500-square-foot office in Carlsbad.

Making Machines Work for Co., Clinic

BIOTECH: Illumina SVP Tackles Challenges

Susan Tousi doesn’t practice medicine, unlike many in her family tree. But Illumina’s senior vice president of product development is making her mark on health.

Tease photo

Daré Bioscience Enters into Development Agreement

Daré Bioscience, a San Diego biopharmaceutical focused on women’s reproductive health, has partnered with Orbis Biosciences to develop long-lasting injectable contraceptives.

Crinetics Pharmaceuticals Raises $63.5M

San Diego biotech Crinetics Pharmaceuticals, taking aim at endocrine-related cancers and endocrine disorders, raised $63.5 million through a Series B financing round.

Alphatec Raises $50 Million, Acquires SafeOp

In a flurry of moves announced March 8, Alphatec acquired SafeOp Surgical, raised $50 million and installed Patrick Miles as CEO.

Ionis Spinout to Commercialize Inotersen

Carlsbad’s Ionis Pharmaceuticals is entrusting Akcea Therapeutics, a spinout of Ionis, to commercialize the drug inotersen ahead of a showdown.

Drug Salvage Operation May Be Salvation for Cancer Victims

John Hood turned a cast-off drug into a multibillion deal.

Tease photo

Edico Takes Big Step Into Medical Records

BIOTECH: Partnership to Put Genomics Data in Files

San Diego’s Edico Genome recently inked a deal to incorporate genomics data into electronic medical records, a cutting-edge space for which the company appears to be well positioned.

Tease photo

Crinetics Pharmaceuticals Raises $63.5 Million in Series B Round

San Diego biotech Crinetics Pharmaceuticals, taking aim at endocrine-related cancers and endocrine disorders, raised $63.5 million through a Series B financing round.

Bankruptcy Sale on Tap for Orexigen Therapeutics

Orexigen’s weight-loss prescription drug, Contrave, didn’t meet sales expectations, running afoul of an agreement with creditors, according to court documents.

Reed to Retire as Sempra CEO

Sempra Energy CEO and president Debra Reed plans to retire in May, ending a 40-year career with Sempra companies, and on the heels of a multi-billion deal.

Alphatec Raises $50 Million, Acquires SafeOp

In a flurry of moves announced this week, Alphatec acquired SafeOp Surgical, raised $50 million and installed Patrick Miles as CEO.

Forge Therapeutics Expands to New Office

San Diego biotech Forge Therapeutics, dedicated to fighting superbugs, is expanding to a 7,000-square-foot space in Torrey Mesa.

Platform Delivers For Halozyme

BIOTECH: Co. Finds Right Balance for Work On Drug, Delivery System

Halozyme Therapeutics seeks big returns on two fronts. Royalties in one could hit nearly $1 billion by 2027. The other holds even bigger potential.

Tease photo

Texas Regulators Approve Sempra Buying Oncor for $9.45B

The Public Utility Commission of Texas on March 8 approved Sempra Energy buying Oncor Electric Delivery, the last remaining regulatory obstacle in a $9.45 billion deal expected to close shortly.

$140M UC San Diego Health Outpatient Pavilion to Debut

On March 12, UC San Diego Health will open the Koman Family Outpatient Pavilion, sporting specialty services for breast, urology, sports medicine and spine care.

Tease photo

Vividion Locks Down $101M Upfront in Celgene Collaboration

The San Diego biotech will receive the payment as part of a four-year collaboration with Celgene.

Poseida Therapeutics Names Mark Gergen as CBO, CFO

Mark J. Gergen has joined San Diego-based Poseida Therapeutics as chief business officer and chief financial officer, bringing 25 years of life sciences experience.

Co.’s Rodent Testing Niche Aims for NASH Treatment

Clients of Carlsbad’s Triangulum Biopharma include the likes of NASA, or National Aeronautics and Space Administration. Yet Triangulum won’t comment on the specific nature of the contract.

Tease photo

Ionis Reports Promising Huntington’s Disease Drug Trial

The Carlsbad drugmaker reported positive early stage data on a potentially groundbreaking drug to reduce the underlying cause of Huntington’s Disease.

Beacon Discovery, Takeda Ink Deal

San Diego’s Beacon Discovery formed a multi-year drug discovery collaboration with Takeda Pharmaceutical Company centered on gastrointestinal disorders.

Okogen Receives $10 Million for Pink Eye Treatment

San Diego’s Okogen received $10 million in Series A funding to advance the company’s lead candidate for viral conjunctivis, commonly known as pink eye.

Ionis Reports Big Gains in Q4, Full 2017 Results

Ionis Pharmaceuticals in Carlsbad Reported $508 million in 2017 revenue, a 46.3 percent increase over the previous year, driven by rising drug royalties.

Sempra Reports 2017 Results

San Diego-based Sempra Energy reported 2017 adjusted earnings of $1.37 billion, up from $1.27 billion the prior year.

Bankruptcy Court Approves Sempra Buying Oncor Holding Company

San Diego-based Sempra Energy has cleared the second to last hurdle in its $9.45 billion acquisition bid for Oncor Electric Delivery, the largest utility in Texas.

NuVasive Reports Q4 Results

Spine surgery and medical device maker NuVasive reported revenue of $271.1 million in the fourth quarter for flat year-over-year growth.

Neuroscience May Belong to the Nimble

MEDICINE: Big Players Bail, But Midsize Cos. Aim for Next Big Thing

Amid big pharma’s waning commitment to neurological disorders like Alzheimer’s, San Diego startups and midstage biotechs see opportunity.

Tease photo

UC San Diego Health Selects Model, Launches Its ACO

MEDICINE: System Is Betting On Treatment Strategies Success

UC San Diego Health has launched a Medicare program that brings the potential for health system savings — that is, if it can meet care and cost requirements.

Tease photo

Sempra, Oncor Deal Reportedly Poised to Receive Approval

San Diego-based Sempra Energy’s $9.45 billion acquisition of Texas energy giant Oncor appears headed for approval.

Ionis Licenses Kidney Drug in Deal Worth up to $330M

Carlsbad’s Ionis Pharmaceuticals has licensed a kidney drug to British giant AstraZeneca, earning $30 million upfront and the potential for $300 million in development and regulatory milestone payments.

AMN Healthcare Reports Solid Growth

Medical staffing company AMN Healthcare reported 2017 fourth quarter revenue of $509 million, a 4 percent year-over-year increase.

Technology Is Key Part of Workflow for Irrigation Company

MANUFACTURING: Its Acquisitions Boost Core Biz, Help Cover New Ground

It’s not uncommon to see sprinklers over-irrigate, turning yards into swamps — or spraying water while it’s raining.

Tease photo

Tandem Diabetes Care Gains Distribution Outside U.S.

San Diego’s Tandem Diabetes Care inked a European distribution deal with Rubin Medical, meaning its insulin pumps will be sold outside the U.S. for the first time.

Dexcom Pilot Program Targets Type 2 Diabetes Population

DEVICES: Company Gains Advantage By Partnering With Insurer

Dexcom aspires to widen its reach beyond Type 1 diabetes. Recently, the San Diego company took a big step toward the goal.

Tease photo

First Blood Test to Evaluate Concussions Receives Green Light

A first-ever test from San Diego’s Banyan Biomarkers to help doctors diagnose traumatic brain injuries has won Federal Drug Administration approval.

Neurocrine Reports Big Gains

San Diego biotech Neurocrine reported a big increase in revenue following the launch of a nervous system drug in late spring, according to financial results released Feb. 13.

Hospital Deal to Fuel Downtown Escondido Construction Boom

An Encinitas developer has struck a deal to buy Palomar Health’s downtown Escondido hospital campus for $18 million, paving the way for a mixed-use project that’s poised to be the epicenter of a construction boom in the area.

Tease photo

Tandem Diabetes Care Lists $60 Million Public Stock Offering

San Diego medical device maker Tandem Diabetes Care recently announced a $60 million public stock offering.

$775M Settlement Spares SDG&E

ENERGY: Utility Still on Hook For Part of San Onofre Costs

San Diego Gas & Electric’s bottom line won’t be impacted by a proposed settlement that will cut by $775 million owed by ratepayers for the closure of the San Onofre nuclear plant.

Sirenas Inks Research Partnership with Bristol-Myers Squibb

Sirenas, a marine-centric biotech in San Diego, has entered into a research agreement with pharmaceutical giant Bristol-Myers Squibb.

Dexcom CEO Is ‘Gadget Guy’ Who Emphasizes Human Side, Grows Co.

Seated beside an oval table in his office, Kevin Sayer squints to read a text on his phone. His blue eyes — the same color as his button-down shirt – light up.

Tease photo

MKO Global Partners Acquired

San Diego-based MKO Global Partners has been acquired by Two Labs, which provides product and commercialization services to pharmaceutical manufacturers.

Former Arcturus CEO Is Challenging His Termination

Joseph Payne is challenging the legality of Arcturus Therapeutics firing him as president and CEO of the company, according to a Feb. 6 letter filed with the U.S. Securities and Exchange Commission.

Hemp Companies Take Root in the Region

AG: Medical Use Explored; Retail Products Find Following

A so-called green rush in San Diego has centered on marijuana. But a crop of companies are capitalizing on a lesser-known part of the cannabis industry: hemp.

Tease photo

Industry Welcomes Suspension of Device Tax

HEALTH CARE: Tax Said to Hurt Staffing, R&D Efforts at Cos.

While San Diego’s medtech hub is cheering the recent suspension of a 2.3 percent excise tax on medical device makers, a full repeal remains the industry’s ultimate goal.

Tease photo